Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 239.00
Bid: 237.00
Ask: 240.00
Change: -1.00 (-0.42%)
Spread: 3.00 (1.266%)
Open: 242.00
High: 242.00
Low: 237.00
Prev. Close: 240.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Contract

18 May 2011 07:00

RNS Number : 7785G
Galliford Try PLC
18 May 2011
 



GALLIFORD TRY SECURES £38 MILLION OF HEALTH AND CARE PROJECTS

 

Galliford Try plc, the housebuilding and construction Group, has secured five projects in the health and care sectors totalling £38 million.

The first contract worth £12.9 million will see Galliford Try undertaking the development of a 54 bed Extra Care community comprising 42 assisted living apartments and 30 independent living units in Surrey for RMH Group. Galliford Try will carry out the extension and alteration of an existing Grade II listed building, along with the demolition of existing buildings and the construction of new buildings. Completion of the project is expected in July 2012.

The second project is as preferred bidder on a £12.4 million project to build Norwood Hall Joint Services Centre in south east London for London Borough of Lambeth in partnership with Building Better Health - under the Lambeth Southwark Lewisham LIFT. The building will be designed to BREEAM's Healthcare Excellent rating.  Following financial close, work will start on site in October 2011 and completion is expected by March 2013.

 

Galliford Try has also reached financial close on three LIFT projects worth a total of £12.7 million in, Cheshire for Renova Developments. The projects comprise the construction of Warrington town centre health centre and Castlefields primary care resource centre along with the internal fit out of Orford Park primary care resource centre. All three projects will achieve a BREEAM Excellent rating.

 

Greg Fitzgerald, Chief Executive, commented:

"We are delighted to secure these projects which build on our extensive expertise in building health and care facilities across the UK, for both public and private sector clients."

 

For further enquiries:

 

Greg Fitzgerald, Chief Executive 01895 855 001

Frank Nelson, Finance Director

Louise Mantio, Communications Director

 

 

Note to Editors

 

Galliford Try has annual revenues of £1.25 billion in housebuilding and construction.

 

The Group's construction order book is now £1.8 billion. £650 million is in building (covering health and education projects through to commercial buildings and sports facilities), £950 million in infrastructure projects (ranging from water, rail, highways and flood alleviation to renewable energy and land remediation) and £200 million in affordable housing contracting.

 

Galliford Try was recently awarded the £790 million Forth Road Crossing project in a four party consortium, and in joint venture with Home Group, was appointed preferred bidder on the £347 million Gateshead regeneration programme.

 

The Group's housebuilding business, Linden Homes, develops distinctive homes across the south and east of England. It completed 1,700 homes in its last financial year, has a landbank of over 10,000 plots and is currently undertaking a significant programme of growth.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGGUQWAUPGGAM
Date   Source Headline
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 202311:00 amRNSAppointment of Joint Broker
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20232:00 pmRNSHolding(s) in Company
21st Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20237:00 amRNSContract
7th Aug 20235:16 pmRNSHolding(s) in Company
7th Aug 20232:00 pmRNSHolding(s) in Company
7th Aug 20237:00 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 202310:00 amRNSTotal Voting Rights
14th Jul 20237:00 amRNSContract
11th Jul 20237:10 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTrading Statement
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20233:30 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20232:32 pmRNSTotal Voting Rights
21st Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20237:00 amRNSSettlement Agreed and Special Dividend
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 202311:00 amRNSConfirmation of Directorate Change
1st Jun 202310:15 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
18th May 20233:30 pmRNSHolding(s) in Company
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20233:00 pmRNSAppointment of Non Executive Director
17th May 20237:00 amRNSTransaction in Own Shares
11th May 20237:10 amRNSContract
10th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 202311:00 amRNSTotal Voting Rights
2nd May 20237:10 amRNSContract
2nd May 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20232:00 pmRNSDirector/PDMR Shareholding
13th Apr 20237:10 amRNSContract
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.